FDA Investigator: Mary E. Farbman

- Mary E. Farbman first started conducting FDA inspections in 2009, with the last inspection in 2013. Over that time, Mary E. Farbman has conducted 13 inspections at 11 companies across 13 sites.

Get Mary Farbman's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Boehringer Ingelheim RCV GmbH & Co KG, Vienna | 2013

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Boehringer Ingelheim RCV GmbH & Co KG, Vienna | 2013

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Merck S.L., Tres Cantos | 2012

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Avecia Biologics (Avecia), Billingham | 2012

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Eurogentec, Seraing | 2011

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Seattle Genetics, Inc., Bothell | 2011

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Health Protection Agency, Salisbury | 2011

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Merz Group Services GmbH, Dessau-Rosslau | 2009

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Lab Of Pharm.& Tox (dup Cf#, See 9610766, Hamburg | 2009

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Human Genome Sciences Inc, Rockville | 2009

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Bio-Technology General (Israel), Ltd., Kiryat Malchi | 2009

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Lonza Biologics Plc, Slough | 2009

Out-of-stock
Mary E. Farbman
Human Drug Form 483

FDA 483 Lonza Biologics Plc, Wokingham | 2009

Out-of-stock
Mary E. Farbman
Human Drug Form 483